Welcome to our dedicated page for Sonnet Biotherapeutc Hldng SEC filings (Ticker: SONN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sonnet BioTherapeutics Holdings Inc. filings document the regulatory record of a clinical-stage oncology biotechnology company built around the FHAB biologic-drug platform. Its disclosures cover shareholder votes, board elections, executive compensation matters, auditor ratification and other proxy governance subjects.
Material-event filings also describe capital-structure activity, including convertible notes, warrants, private-placement proceeds and Nasdaq continued-listing compliance. Additional 8-K disclosures record employment and compensation arrangements, stockholder meeting results, material agreements, operating and financial results, and risk-related matters tied to the company’s biotechnology business and public-company status.